Cerebral Angiography Market Expects To Reach US$ 70 Million By 2027

According to Fact.MR, a market research and competitive intelligence provider, the global sales of cerebral angiography is anticipated to reach a valuation of US$ 70 million by the end of 2027.

Growing cerebral angiography demand in hospitals is attributed to the availability of skilled and experienced medical professionals, employment of detecting technology in radiology departments to identify blood vessel damage brought on by trauma or injury, diagnose cardiovascular illnesses, including artery narrowing & detect aneurysms, and advancements in diagnostic technology

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.factmr.com/connectus/sample?flag=S&rep_id=7693

Growing cerebral angiography demand in hospitals is attributed to the availability of skilled and experienced medical professionals, employment of detecting technology in radiology departments to identify blood vessel damage brought on by trauma or injury, diagnose cardiovascular illnesses, including artery narrowing & detect aneurysms, and advancements in diagnostic technology.

Rapid Product Approval Processes and Increasing Angiography Device Usage in the U.S.

The market in the U.S. is expanding due to the widespread use of minimally-invasive treatments, the availability of reimbursements, rising adoption of cerebral thrombectomy devices, the growing elderly population, a strong network of medical device manufacturers, and the rising number of hospitals with lucrative funding prospects. Cardiovascular disease treatment with 3D printing is becoming more popular, and it may also be used to prevent disease in the future. Using heart valves that are 3D manufactured from living tissue, aortic valve failure can be addressed without the use of prosthetic valves. The market for cerebral angiography is being driven by healthcare industry innovation and investments.

The U.S. market is expanding due to rapid product approval processes and increasing angiography device usage as a result of the high volume of angiography screening procedures being conducted.

𝐒𝐡𝐚𝐫𝐞 𝐘𝐨𝐮𝐫 𝐑𝐞𝐪𝐮𝐢𝐫𝐞𝐦𝐞𝐧𝐭𝐬 & 𝐆𝐞𝐭 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐞𝐝 𝐑𝐞𝐩𝐨𝐫𝐭𝐬- https://www.factmr.com/connectus/sample?flag=RC&rep_id=7693

Key Takeaways from Market Study

• Sales of cerebral angiography devices are expected to rise rapidly at a CAGR of 8.8% through 2027.
• The global cerebral angiography market is currently valued at US$ 46 million.
• Market in Japan is anticipated to expand at a CAGR of 5% over the forecast period.
• Market in Canada is set to progress at a CAGR of 8% through 2027.

Segmentation of Cerebral Angiography Industry Research

By Technology :

o Magnetic Resonance Angiography
o Computed Tomography
o Ultrasound
o Nuclear Imaging
o X-ray

By End User :

o Hospitals
o Diagnostic Imaging Centers
o Others

By Region :

o North America
o Europe
o Asia Pacific
o Latin America
o Middle East & Africa

𝐆𝐞𝐭 𝐀𝐜𝐜𝐞𝐬𝐬 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.factmr.com/checkout/7693

Winning Strategy

Key companies are concentrating on product updates and new product development. Market players are seeking to develop cutting-edge, patient-focused products. By including a wide range of products in their portfolios, top industry players are concentrating on bolstering their positions in the market.

Key providers of cerebral angiography devices have been seen collaborating to maintain their market position as well as establish their geographic presence through effective distribution networks.

For instance,

• The Discovery IGSTM 740 mobile angiography system from GE Healthcare was recently unveiled. Users can experience exceptional comfort and control with Discovery's rail-free design and versatile wide-bore C-arm configuration. Huge anatomies are also covered by its large detector in both 2D and 3D.

More Valuable Insights on Offer

Fact.MR, in its new offering, presents an unbiased analysis of the global cerebral angiography market, presenting historical demand data (2017-2021) and forecast statistics for the period of 2022-2027.

The study divulges essential insights on the market on the basis of technology (magnetic resonance angiography, computed tomography, ultrasound, nuclear imaging, X-ray) and end user (hospitals, diagnostic imaging centers, others), across five major regions (North America, Europe, Asia Pacific, Latin America, and MEA).

𝐂𝐡𝐞𝐜𝐤 𝐨𝐮𝐭 𝐦𝐨𝐫𝐞 𝐫𝐞𝐥𝐚𝐭𝐞𝐝 𝐬𝐭𝐮𝐝𝐢𝐞𝐬 𝐩𝐮𝐛𝐥𝐢𝐬𝐡𝐞𝐝 𝐛𝐲 𝐅𝐚𝐜𝐭.𝐌𝐑 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡: https://www.globenewswire.com/news-release/2022/10/03/2526452/0/en/Sales-of-Laparotomy-Sponges-Are-Projected-to-Reach-a-Market-Size-of-US-1-6-billion-By-2027-Radiopaque-Laparotomy-Sponges-Widely-Used-in-Thoracic-Surgical-Procedures-Report-Fact-MR.html

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range - from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories.

This release was published on openPR.